We provide technical consulting and expertise across the product journey, helping our clients maximize the value of their available evidence and addressing gaps to support successful access and reimbursement strategies within their target markets.
Our team consists of technical experts including health economists, statisticians, medical writers, in-house graphic designers, commercial assessment analysts, systematic reviewers, and COA specialists, enabling us to provide bespoke, end-to-end solutions across the product lifecycle with the goal of optimizing market access.
Our experts can streamline your clinical development strategy with fit-for-purpose PROs and other COA instruments to support regulatory, communication, and reimbursement strategies.
Offerings include:
We design, construct, data populate, test and adapt economic models to demonstrate product value and increase likelihood of positive funding decisions in your target markets.
Offerings include:
Clarivate can develop, coordinate and deliver a robust HTA strategy to effectively convey the benefit of your asset for favorable reimbursement outcomes in target markets.
Offerings include:
Clarivate can develop robust, reproducible, high quality systematic literature reviews and indirect treatment comparisons to support HTA submissions and Market Access activities. Our offerings include:
Develop a robust value proposition that resonates with payers and providers and design value-focused, evidence-based messaging to engage customers.
Offerings include:
I am the Senior Director of Clinical Outcomes Assessment at Clarivate. We’d love to hear from you and see how we can help provide insight across your drug and device lifecycle.
Learn more about my expertise or get in touch by clicking below.